Welcome to NewPressRelease.com a free press release service. Publishing press releases for Public Relations never been easier. Just register (it's free and it takes less then a 1 minute) then use Submit Press Release. Our services aim to help you reach journalists and to improve visibility in search engine listings, so you can get the most publicity possible.

Aarkstore Enterprise || What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 201

Health and Fitness

(Free Press Release) Aarkstore announce a new report What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015 through its vast collection of market research report.

Aarkstore Enterprise || What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 201



Aarkstore.com announces, a new market research report is available in its vast collection:

What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 2011-2015


The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms for the treatment or management of diseases or injuries. What are the products that lead the market now and what can we expect to see in the coming years?

This Company report, What's Next in Biologics? represents our latest research into the market for non-vaccine biological drugs and the companies who compete in the market. The following are among the data points in this report:

· Biopharmaceutical Pipeline for Significant Companies

· Market Size of Biopharmaceuticals

o Monoclonal Antibodies (mAbs)

o Recombinant Hormones and Proteins (rDNA)

o Interferons and

o Other Biologics

· Biopharmaceutical Market Forecast to 2015

· Products in Development: New Compound vs. Additional Indications

· Competitor Market Shares for Biopharmaceuticals

· Autoimmune, Cancer, Cardiovascular and Hormone Treatments Market Sizes and Competitor Shares

· Drug Development Cost Progression

· Leading Biotech Therapies by 2010 Revenues

· Population and Healthcare Spending Trends

· Select Biotechnology Drugs Approved for Marketing

The biologics industry encompasses a wide range of products including monoclonal antibodies, blood products, vaccines, and some diagnostics and devices. For the purpose of this study, Company has focuses on those biologics that are used in conjunction with or as a replacement to traditional pharmaceutical treatment. For example, treatments for cancer, growth disorders, autoimmune diseases and blood disorders. This study excludes products such as vaccines—including prophylactic vaccines—which are covered in-depth in separate Kalorama studies. The following is among the qualitative analysis found in this report:

· The Role Government Incentives Will Play in the Future Biotech Market

· Pharmaceutical Regulatory Exclusivity

· Biosimilars: Where They Stand and What We Can Expect

· The Largest Areas of Research for Biopharmaceuticals

· Improvements in the Next Generation of Biologics

· The Impact of Aging Populations on Biotechnology Market Development

· Health Care Reform: What it Means

· Recent Mergers, Acquisitions, and Collaborations

· Contributors to R&D Success

· Targeted Cancer Therapy

· Genome Sequencing for Personalized Healthcare

· The Role of Contract Research Organizations

In the traditional pharmaceutical market, the pipeline is struggling to produce strong therapies and the growing number of drugs losing patent protection will more than offset revenues generated from new developments. For now, the biotechnology market is spared the impact of this setback as the path to generic or biosimilar development is more involved and the number of biotechnology drugs facing generic competition remains limited.

Table of Contents :


  • Introduction
  • Scope and Methodology
  • Biopharmaceutical Market Overview
  • Issues and Trends Affecting Market
  • Leading Companies


  • Overview of Biopharmaceutical
  • General Biotech Terms
  • Expanded Options in Treating Diseases
  • Disease Descriptions
    • Autoimmune Diseases
    • Cardiovascular and Blood Disorders
    • Cancer
    • Hormone Disorders
    • Infectious Diseases
    • Neurological Disorders
  • Research & Development Overvie

For More Related Reports Please follow the link :

Aarkstore Enterprise || What's Next in Biologics? (mAbs, rDNA, Interferons, and Other Biologics) 201

Source: Press Release



If you have any questions regarding information in this press release, please contact the person listed as the Author or use the contact informations published in the press release. Please do not attempt to contact NewPressRelease.com. We are unable to assist you with any information regarding this release. NewPressRelease.com disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.

Related Items

All press release information on this site, including free press releases, is solely based on what our users submit. NewPressRelease.com disclaims that any right and responsibility for the information goes to the user who submit the press release. Some press release may be confusing without additional explanation. You should contact the provider with any questions about the information presented. In case some press release damages your benefits or violate your rights in any way, please contact us and we'll remove it immediately.

Copyright © 2008 - 2018 Free Press Release by NewPressRelease.com